One of the explanations is that PLK1 plays an oncogenic role and is constitutively required in papillary carcinoma during the early phase, while it is less necessary for the development of this carcinoma during the advanced stage (64–66). Here, PLK1 is linked to thyroid gland papillary carcinoma.